Sort   by:  
 Page size 
UnknownImpact of antiretroviral therapy intensification with C-C motif chemokine receptor 5 antagonist maraviroc on HIV-associated neurocognitive impairment.
Not available
S-EPMC10538417 | biostudies-literature
UnknownDysregulation of complement components associated with inflammation and coagulation in virally suppressed people living with HIV.
Not available
S-EPMC12453596 | biostudies-literature
UnknownMitochondrial oxidative phosphorylation in peripheral blood mononuclear cells is decreased in chronic HIV and correlates with immune dysregulation.
Not available
S-EPMC7192478 | biostudies-literature
UnknownCenicriviroc inhibits trans-endothelial passage of monocytes and is associated with impaired E-selectin expression.
Not available
S-EPMC6258344 | biostudies-literature
UnknownImmunologic Change over 72 Weeks Following Raltegravir- Versus Efavirenz-Based Therapy in HIV/HCV-Coinfected Individuals in Vietnam.
Not available
S-EPMC10027344 | biostudies-literature
UnknownNeurocognitive Trajectories After 72 Weeks of First-Line Anti-retroviral Therapy in Vietnamese Adults With HIV-HCV Co-infection.
Not available
S-EPMC7996090 | biostudies-literature
UnknownComparative DNA Methylation Profiling Reveals an Immunoepigenetic Signature of HIV-related Cognitive Impairment.
Not available
S-EPMC5024304 | biostudies-literature
UnknownShort Communication: Carotid Artery Plaque Burden in HIV Is Associated with Soluble Mediators and Monocytes.
Not available
S-EPMC7703087 | biostudies-literature
UnknownPre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.
Not available
S-EPMC2825289 | biostudies-literature
UnknownTelmisartan reduces systemic inflammation and alters the renin-angiotensin system in mild COVID-19.
Not available
S-EPMC12780154 | biostudies-literature
Sort   by:  
 Page size